- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03453385
Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT) (CONNECT)
September 1, 2023 updated by: Matthew Carpenter, Medical University of South Carolina
The purpose of this study is to measure changes in smoking behavior during and following sampling of an e-cigarette product.
E-cigarettes are classified by the US Food and Drug Administration (FDA) as a tobacco product, though they contain no tobacco.
Unlike regular cigarettes, which are burned (creating smoke that is inhaled), e-cigarettes include a heating element that vaporizes nicotine.
E-cigarettes are likely much safer than conventional cigarettes, but they may not be entirely safe.
We are testing the effects of one specific ecigarette (NJoy) on naturalistic changes in smoking behavior.
Neither the tobacco industry nor any ecigarette manufacturer provides support of any kind to this study.
There is no requirement to quit smoking in this study, nor is there any requirement to use e-cigarettes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Eligible smokers, once consented, will be randomized to receive a sample of ecigarettes (NJoy Pre-Filled Tank; n=440) or not (n=220).
E-cigarette samples are inclusive of a battery and self-contained tanks of assorted flavors to last up to 4 weeks.
Participants will be recruited nationally, but a subset (N=120) will be recruited locally to allow for biomarker collection .
Our two-fold purpose is to 1) characterize naturalistic uptake of e-cigarettes, and 2) assess impact of e-cigarette uptake on smoking behavior.
All smokers will be asked to provide smoking diary data, captured electronically, daily for 4 weeks.
More substantive phone assessment will track smoking and related behaviors at baseline (Day 0) and +10, +17, and +24 days (weekly during initial 3 weeks, following brief lag for delays in product mailing), and at +1, +3, and +6 months.
Study Type
Interventional
Enrollment (Actual)
638
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- age 21+,
- current smoker
- regular use of email OR capacity to receive SMS text and internet access
- additional smoking and health criteria determined at screening
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Participants will not receive an NJOY electronic cigarette to sample and will continue smoking their usual cigarettes as much or as little as they would like.
|
|
|
Experimental: Sampling
Participants will receive an NJOY electronic cigarette to sample and will continue smoking their usual cigarettes as much or as little as they would like.
|
An e-cigarette and four weeks of e-liquid provided to participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
E-cig Use at End of Sampling Period
Time Frame: at week 4
|
percentage of participants reporting using an e-cigarette
|
at week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Conversion
Time Frame: Study enrollment through end of 6-month follow up
|
Percentage of participants who purchase an e-cigarette or additional nicotine liquid on their own
|
Study enrollment through end of 6-month follow up
|
|
Smoking Cessation
Time Frame: at 6-month follow-up
|
Point prevalence abstinence from conventional smoking
|
at 6-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 24, 2018
Primary Completion (Actual)
September 8, 2022
Study Completion (Actual)
September 8, 2022
Study Registration Dates
First Submitted
February 27, 2018
First Submitted That Met QC Criteria
February 27, 2018
First Posted (Actual)
March 5, 2018
Study Record Updates
Last Update Posted (Actual)
September 11, 2023
Last Update Submitted That Met QC Criteria
September 1, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 493
- 1R01CA210625-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University GhentActive, not recruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Virginia Polytechnic Institute and State UniversityActive, not recruitingCigarette Smoking Behavior | Smoking Behaviors | CigaretteUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Smoking Behaviors | Smoking Habit | Smoking (Tobacco) AddictionUnited States
-
Johns Hopkins UniversityNational Center for Advancing Translational Sciences (NCATS); Community Partnership...CompletedSmoking Cessation | Smoking Reduction | Smoking, TobaccoUnited States
Clinical Trials on Electronic Cigarette
-
Virginia Commonwealth UniversityCompletedElectronic CigarettesUnited States
-
Massachusetts General HospitalWithdrawn
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsCompletedCardiovascular Risk Factor | Nicotine DependenceUnited States
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI); Food and Drug Administration...CompletedCardiovascular Risk Factor | Nicotine DependenceUnited States
-
Karolinska InstitutetCompleted
-
GWT-TUD GmbHTerminated
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedEndothelial Dysfunction | Biochemical MarkersUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Roswell Park Cancer InstituteCompleted
-
Queen's University, BelfastUnknownAcute Lung InjuryUnited Kingdom
-
University of AthensUnknown